Trinity Biotech Announces Q3 2024 Financial Results

9 hours ago · Q3 2024 total revenue of $15.2 million grew +3% Y/Y based on strong demand and output in the TrinScreen HIV business Point-of-Care product revenue of $4.3 million grew 60% …

CouponFollow Extension

3%
OFF

Trinity Biotech Announces Q3 2024 Financial Results

2 weeks from now

9 hours ago · Q3 2024 total revenue of $15.2 million grew +3% Y/Y based on strong demand and output in the TrinScreen HIV business Point-of-Care product revenue of $4.3 million grew 60% …

businessinsider.com

$0.46
OFF

Trinity Biotech Announces Q3 2024 Financial Results

2 weeks from now

9 hours ago · The basic and diluted loss per ADS for Q3 2024 was $0.46 compared to $1.55 in Q3 2023. Liquidity. The Group’s cash balance decreased to $2.8m at the end of Q3 2024 from …

globenewswire.com

3%
OFF

Trinity Biotech Announces Q3 2024 Financial Results - Yahoo Finance

2 weeks from now

9 hours ago · Q3 2024 total revenue of $15.2 million grew +3% Y/Y based on strong demand and output in the TrinScreen HIV business Point-of-Care product revenue of $4.3 million grew 60% …

yahoo.com

6%
OFF

Trinity Biotech : Announces Q3 2024 Financial Results Form 6 K

2 weeks from now

5 hours ago · Our clinical laboratory revenue was $10.8m in Q3 2024, a decrease of $1.2m or 9.6% compared to $12.0m in Q3 2023. There was a strong performance in the quarter from …

marketscreener.com

3%
OFF

Trinity Biotech Announces Q3 2024 Financial Results - Yahoo Finance

2 weeks from now

23 hours ago · Q3 2024 total revenue of $15.2 million grew +3% Y/Y based on strong demand and output in the TrinScreen HIV business Point-of-Care product revenue of $4.3 million grew …

yahoo.com

3%
OFF

Trinity Biotech Announces Q3 2024 Financial Results

2 weeks from now

9 hours ago · Trinity Biotech (TRIB) reported Q3 2024 total revenue of $15.2 million, up 3% year-over-year, driven by strong Point-of-Care product revenue growth of 60% Y/Y to $4.3 …

stocktitan.net

$0.46
OFF

Trinity Biotech Announces Q3 2024 Financial Results

2 weeks from now

9 hours ago · The basic and diluted loss per ADS for Q3 2024 was $0.46 compared to $1.55 in Q3 2023.. Liquidity. The Group’s cash balance decreased to $2.8m at the end of Q3 2024 …

marketscreener.com

3%
OFF

Trinity Biotech : Announces Q3 2024 Financial Results Form 6 K

2 weeks from now

5 hours ago · Trinity Biotech Announces Q3 2024 Financial Results Q3 2024 total revenue of $15.2 million grew +3% Y/Y based on strong demand and output in the TrinScreen...

marketscreener.com

3%
OFF

Trinity Biotech Announces Q3 2024 Financial Results - ADVFN

2 weeks from now

23 hours ago · Q3 2024 total revenue of $15.2 million grew +3% Y/Y based on strong demand and output in the TrinScreen HIV business Point-of-Care...

advfn.com

3%
OFF

TRIB - Trinity Biotech Announces Q3 2024 Financial Results

2 weeks from now

23 hours ago · Q3 2024 total revenue of $15.2 million grew +3% Y/Y based on strong demand and output in the TrinScreen HIV business Point-of-Care product revenue of.

marketwirenews.com

FAQs about Trinity Biotech Announces Q3 2024 Financial Results Coupon?

What did Trinity biotech do in 2024?

DUBLIN, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced the Company’s results for the quarter ended September 30, 2024. Key Highlights and Developments ...

How much did Trinity biotech make in a quarter?

Trinity Biotech plc (NASDAQ:TRIB) issued its earnings results on Wednesday, August, 14th. The company reported ($0.55) EPS for the quarter, beating analysts' consensus estimates of ($0.65) by $0.10. The firm earned $15.84 million during the quarter, compared to analysts' expectations of $15.75 million. When did Trinity Biotech's stock split? ...

Does Trinity biotech (Trib) stock rise post-market?

Trinity stock soars post-market on raised guidance, increased capacity SA NewsMon, Aug. 26 Trinity Biotech plc (TRIB) Q2 2024 Earnings Call Transcript SA TranscriptsFri, Aug. 16 Trinity Biotech reports Q2 results SA NewsWed, Aug. 14 Trinity Biotech obtains extension to demonstrate compliance with Nasdaq listing requirements SA NewsTue, Aug. 06 ...

What time is Trinity biotech (Trib) Q1 2024 conference call?

Trinity Biotech plc (NASDAQ:TRIB) Q1 2024 Results Conference Call May 23, 2024 8:30 AM ET Company Participants Eric Ribner - Investor Relations John Gillard - Chief Executive Officer Des Fitzgerald -... ...

Who owns Trinity Biotech stock?

In the past three months, Trinity Biotech insiders have not sold or bought any company stock. Only 8.20% of the stock of Trinity Biotech is held by insiders. 78.97% of the stock of Trinity Biotech is held by institutions. High institutional ownership can be a signal of strong market trust in this company. ...